The Global Bipolar Disorder Market Size was valued at USD 5.5 Billion in 2023 and the total Global Bipolar Disorder revenue is expected to grow at a CAGR of 3.4 % from 2024 to 2030, reaching nearly USD 6.95 Billion by 2030Global Bipolar Disorder Market Overview
Bipolar disorders (BD) are a group of severe lifelong disorders that are associated with staggering loss of human capital, loss of healthy living years as well as lifespan. Although mania is the defining feature of Global Bipolar Disorder I disorder, and hypomania with at least one depressive episode defines Global Bipolar Disorder II disorder, it is well-established that depressive symptoms and episodes are the predominant illness presentation. The predominance of depressive symptoms across Global Bipolar Disorder subtypes is apparent not only at the first illness presentation but also along the longitudinal course.To know about the Research Methodology :- Request Free Sample Report Surged in the prevalence of mental health disorders has propelled the market growth in 2023. The Global Bipolar Disorder market is expected to grow during the forecast period owing to increased stress among adults, lifestyle changes, increased high demand for anti-depressants, and advances in the combination drug therapeutic market that have boosted the Bipolar Disorder market growth. Bipolar disorder is a complex and difficult disorder to treat as awareness of available treatments and specific benefits and hazards, along with early and accurate diagnosis, facilitate better outcomes for those suffering from extremely distressing and disabling chronic illnesses. Lithium remains the most useful drug for acute treatment and prevention in Global Bipolar Disorder treatment. With the changing perspective on mental health, the demand for natural Global Bipolar Disorder meds or drugs is anticipated to grow among patients suffering from such diseases. 1. According to MMR analysis, approximately 34% of individuals with Bipolar disorder attempt suicide and 15% to 20% of people with Bipolar disorder die by suicide. 2.Sumitomo Dainippon Pharma, along with its subsidiary Sunovion Pharmaceuticals, is one of the leading players in the Bipolar disorder market and is expected to remain during the forecast period.
Global Bipolar Disorder Market Dynamics
Increased Awareness, Government Initiatives, and Medical Advancements in Global Bipolar Disorder Market Increasing public awareness of the disease and providing affordable, accessible diagnosis assistance has surged the market growth. Global Bipolar Disorder Market awareness also aims to eliminate several stereotypes related to Bipolar Disorder, which weaken people's self-confidence in asking for help and has been accelerating the market growth. The increase in the government's initiatives to develop an educated society is increasing the number of people seeking outpatient treatment has boosted the growth of the market. Scientific successes or medical research have extended the field of medicine to include new aspects of diseases, defining them in several categories. The growing capabilities of medicine to cover all aspects of diseases are leading to an increase in diagnoses, which is driving the global market for Bipolar disorder.Challenges in Global Bipolar Disorder Diagnosis and Treatment The complex nature of Bipolar disorder and its overlapping symptoms with other mental illnesses make it challenging to diagnose accurately. Misdiagnosis or delayed diagnosis hinders effective treatment and management of the disease. A lack of awareness among the public and health professionals about Bipolar disorder has resulted in underdiagnoses and under treatment. Long-term treatment and medication are frequently necessary for individuals with Bipolar disorder. The Bipolar Disorder medication side effects, stigma, lack of social support, and various symptoms hinder treatment adherence. The increase in the risk of recurrence and worsening of the disease is heightened by inadequate treatment adherence. Disparities in access to mental health services, including limited access to mental health professionals, inadequate insurance coverage, and financial constraints, created significant challenges for people with Bipolar disorder to receive timely and appropriate help as a result it hindered the market growth.
Global Bipolar Disorder Market Segment Analysis
Based on Treatment Type, the Mood stabilizers Segment holds the highest market share at 54.00 % with a growing CAGR of 4.78% during the forecast period. Mood stabilizers are a class of medications used in the management and treatment of Bipolar disorder. Bipolar disorder or manic-depression is a severe and common psychiatric illness that is often treated with mood-stabilizing drugs. In 2023, there has been a significant surge in the use of mood stabilizers, primarily as psychiatric drugs for treating mood disorders like Bipolar disorder. The market has grown significantly owing to various factors such as the increasing prevalence of mental illness, the increasing geriatric population, and increasing awareness and acceptance of mental health treatments. The pharmaceutical industry is striving to create new formulations that exhibit superior effectiveness, side effects, and long-lasting characteristics. In addition, precision medicine and personalized therapies hold promising opportunities for tailoring mood stabilizers to specific patient needs. Mood stabilizers, such as Carbamazepine, Lamotrigine, Valproate, and Asenapine, which are used to cure Bipolar disorder resulting in propelled in the market growth.
Global Bipolar Disorder Market Regional Insights
North America dominated the Global Bipolar Disorder Market with the highest market share accounting for 53.80% in 2023, the region is expected to grow during the forecast period and maintain its dominance by 2030. The market is fuelled by the increasing prevalence of mood disorders and the growing demand for effective treatment options. Major factors that are driving the growth of the Bipolar disorder treatment market include increased awareness of the condition, improved healthcare system, and higher rates of onset of symptoms associated with high levels of stress and poor lifestyle. The increasing prevalence of ADHD in the region has increased the demand for ADHD therapists. With its advanced healthcare infrastructure and high healthcare spending, the United States has a significant market share in the global market. The US market makes up the majority of total global sales, contributing to more than 80% owing to the large Bipolar disorder population, combined with the high price of medication in the country. 1. 7 million Americans have Bipolar disorder. Nearly one-third of patients with major depressive disorder and nearly one-third of those with schizophrenia are defined as having treatment-resistant forms of these illnesses. 2. 82% of biopharmaceutical companies with research projects in areas including mental health expect substantial impacts on the pipeline. Many Americans grapple with Bipolar disorder, a mental health condition affecting approximately 4.4% of U.S. adults, translating to around 11.3 million individuals.Global Bipolar Disorder Market Competitive Landscape 1. In May 2023, AbbVie’s acquisition of Allergan, the deal brought together two major pharmaceutical companies with stakes in the Global Bipolar Disorder treatment market. AbbVie’s portfolio includes established medications like lithium, while allergens had a presence through its central nervous system drugs. The combined entity is expected to leverage its broader portfolio and resources to drive further research and development in various therapeutic areas, potentially including Bipolar disorder treatments. 2.In 2023, there was a rise in the development and adoption of digital health solutions tailored for Bipolar disorder management. Mobile apps, wearable devices, and online platforms were designed to assist patients in tracking mood changes, medication adherence, and accessing support resources.
Global Bipolar Disorder Market Scope: Inquiry Before Buying
Global Bipolar Disorder Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 5.5 Bn. Forecast Period 2024 to 2030 CAGR: 3.4% Market Size in 2030: US $ 6.95 Bn. Segments Covered: by Type Global Bipolar Disorder I Disorder Global Bipolar Disorder II Disorder Cyclothymic Disorder by Treatment Type Mood Stabilizer Antipsychotics Antidepressant by Mechanism of Action Selective Serotonin Reuptake Inhibitor Serotonin Norepinephrine Reuptake Inhibitor Tricyclic Antidepressant Drug Benzodiazepines Beta Blockers Global Bipolar Disorder Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Bipolar Disorder Key Players
1. Johnson & Johnson (United States) 2. Pfizer Inc. (United States) 3. AstraZeneca plc (United Kingdom) 4. Eli Lilly and Company (United States) 5. Bristol Myers Squibb (United States) 6. Otsuka Pharmaceutical Co., Ltd. (Japan) 7. Allergan plc (Ireland) 8. AbbVie Inc. (United States) 9. GlaxoSmithKline plc (United Kingdom) 10. Novartis AG (Switzerland) 11. Lundbeck (Denmark) 12. Alkermes plc (Ireland) 13. Sumitomo Dainippon Pharma Co., Ltd. (Japan) 14. Takeda Pharmaceutical Company Limited (Japan) 15. Mitsubishi Tanabe Pharma Corporation (Japan) 16. Sunovion Pharmaceuticals Inc. (United States) 17. Boehringer Ingelheim International GmbH (Germany) 18. Janssen Pharmaceuticals, Inc. (United States) 19. Mylan N.V. (United States) 20. Recordati S.p.A. (Italy) Frequently Asked Questions: 1] What is the projected market size & and growth rate of the Global Bipolar Disorder Market? Ans. The Global Bipolar Disorder Market size was valued at USD 5.5 Billion in 2023 and the total Global Bipolar Disorder revenue is expected to grow at a CAGR of 3.4 % from 2024 to 2030, reaching nearly USD 6.95 Billion By 2030 2] What segments are covered in the Global Bipolar Disorder Market report? Ans. The segments covered in the Global Bipolar Disorder Market report are based on Type, Treatment Type, and Mechanism of action. 3] Which region is expected to hold the highest share in the Global Bipolar Disorder Market? Ans. The North American region is expected to hold the highest share of the Global Bipolar Disorder Market. 4] What are the growth drivers for the Global Bipolar Disorder Market? Ans. The rising prevalence of mental health disorders, etc. is expected to be the major driver for the Global Bipolar Disorder Market. 5] What is the forecast period for the Global Bipolar Disorder Market? Ans. The forecast period for the Global Bipolar Disorder Market is 2024-2030.
1. Bipolar Disorder Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Bipolar Disorder Market: Dynamics 2.1. Bipolar Disorder Market Trends by Region 2.1.1. North America Bipolar Disorder Market Trends 2.1.2. Europe Bipolar Disorder Market Trends 2.1.3. Asia Pacific Bipolar Disorder Market Trends 2.1.4. Middle East and Africa Bipolar Disorder Market Trends 2.1.5. South America Bipolar Disorder Market Trends 2.2. Bipolar Disorder Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Bipolar Disorder Market Drivers 2.2.1.2. North America Bipolar Disorder Market Restraints 2.2.1.3. North America Bipolar Disorder Market Opportunities 2.2.1.4. North America Bipolar Disorder Market Challenges 2.2.2. Europe 2.2.2.1. Europe Bipolar Disorder Market Drivers 2.2.2.2. Europe Bipolar Disorder Market Restraints 2.2.2.3. Europe Bipolar Disorder Market Opportunities 2.2.2.4. Europe Bipolar Disorder Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Bipolar Disorder Market Drivers 2.2.3.2. Asia Pacific Bipolar Disorder Market Restraints 2.2.3.3. Asia Pacific Bipolar Disorder Market Opportunities 2.2.3.4. Asia Pacific Bipolar Disorder Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Bipolar Disorder Market Drivers 2.2.4.2. Middle East and Africa Bipolar Disorder Market Restraints 2.2.4.3. Middle East and Africa Bipolar Disorder Market Opportunities 2.2.4.4. Middle East and Africa Bipolar Disorder Market Challenges 2.2.5. South America 2.2.5.1. South America Bipolar Disorder Market Drivers 2.2.5.2. South America Bipolar Disorder Market Restraints 2.2.5.3. South America Bipolar Disorder Market Opportunities 2.2.5.4. South America Bipolar Disorder Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Bipolar Disorder Industry 2.8. Analysis of Government Schemes and Initiatives For Bipolar Disorder Industry 2.9. Bipolar Disorder Market Trade Analysis 2.10. The Global Pandemic Impact on Bipolar Disorder Market 3. Bipolar Disorder Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 3.1.1. Global Bipolar Disorder I Disorder 3.1.2. Global Bipolar Disorder II Disorder 3.1.3. Cyclothymic Disorder 3.2. Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 3.2.1. Mood Stabilizer 3.2.2. Antipsychotics 3.2.3. Antidepressant 3.3. Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 3.3.1. Selective Serotonin Reuptake Inhibitor 3.3.2. Serotonin Norepinephrine Reuptake Inhibitor 3.3.3. Tricyclic Antidepressant Drug 3.3.4. Benzodiazepines 3.3.5. Beta Blockers 3.4. Bipolar Disorder Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Bipolar Disorder Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 4.1.1. Global Bipolar Disorder I Disorder 4.1.2. Global Bipolar Disorder II Disorder 4.1.3. Cyclothymic Disorder 4.2. North America Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 4.2.1. Mood Stabilizer 4.2.2. Antipsychotics 4.2.3. Antidepressant 4.3. North America Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 4.3.1. Selective Serotonin Reuptake Inhibitor 4.3.2. Serotonin Norepinephrine Reuptake Inhibitor 4.3.3. Tricyclic Antidepressant Drug 4.3.4. Benzodiazepines 4.3.5. Beta Blockers 4.4. North America Bipolar Disorder Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 4.4.1.1.1. Global Bipolar Disorder I Disorder 4.4.1.1.2. Global Bipolar Disorder II Disorder 4.4.1.1.3. Cyclothymic Disorder 4.4.1.2. United States Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 4.4.1.2.1. Mood Stabilizer 4.4.1.2.2. Antipsychotics 4.4.1.2.3. Antidepressant 4.4.1.3. United States Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 4.4.1.3.1. Selective Serotonin Reuptake Inhibitor 4.4.1.3.2. Serotonin Norepinephrine Reuptake Inhibitor 4.4.1.3.3. Tricyclic Antidepressant Drug 4.4.1.3.4. Benzodiazepines 4.4.1.3.5. Beta Blockers 4.4.2. Canada 4.4.2.1. Canada Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 4.4.2.1.1. Global Bipolar Disorder I Disorder 4.4.2.1.2. Global Bipolar Disorder II Disorder 4.4.2.1.3. Cyclothymic Disorder 4.4.2.2. Canada Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 4.4.2.2.1. Mood Stabilizer 4.4.2.2.2. Antipsychotics 4.4.2.2.3. Antidepressant 4.4.2.3. Canada Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 4.4.2.3.1. Selective Serotonin Reuptake Inhibitor 4.4.2.3.2. Serotonin Norepinephrine Reuptake Inhibitor 4.4.2.3.3. Tricyclic Antidepressant Drug 4.4.2.3.4. Benzodiazepines 4.4.2.3.5. Beta Blockers 4.4.3. Mexico 4.4.3.1. Mexico Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 4.4.3.1.1. Global Bipolar Disorder I Disorder 4.4.3.1.2. Global Bipolar Disorder II Disorder 4.4.3.1.3. Cyclothymic Disorder 4.4.3.2. Mexico Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 4.4.3.2.1. Mood Stabilizer 4.4.3.2.2. Antipsychotics 4.4.3.2.3. Antidepressant 4.4.3.3. Mexico Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 4.4.3.3.1. Selective Serotonin Reuptake Inhibitor 4.4.3.3.2. Serotonin Norepinephrine Reuptake Inhibitor 4.4.3.3.3. Tricyclic Antidepressant Drug 4.4.3.3.4. Benzodiazepines 4.4.3.3.5. Beta Blockers 5. Europe Bipolar Disorder Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.2. Europe Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.3. Europe Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4. Europe Bipolar Disorder Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.1.2. United Kingdom Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.1.3. United Kingdom Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.2. France 5.4.2.1. France Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.2.2. France Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.2.3. France Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.3.2. Germany Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.3.3. Germany Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.4.2. Italy Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.4.3. Italy Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.5.2. Spain Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.5.3. Spain Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.6.2. Sweden Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.6.3. Sweden Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.7.2. Austria Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.7.3. Austria Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 5.4.8.2. Rest of Europe Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 5.4.8.3. Rest of Europe Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6. Asia Pacific Bipolar Disorder Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.2. Asia Pacific Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.3. Asia Pacific Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4. Asia Pacific Bipolar Disorder Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.1.2. China Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.1.3. China Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.2.2. S Korea Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.2.3. S Korea Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Japan Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.3.3. Japan Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.4. India 6.4.4.1. India Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.4.2. India Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.4.3. India Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Australia Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.5.3. Australia Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Indonesia Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.6.3. Indonesia Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Malaysia Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.7.3. Malaysia Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Vietnam Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.8.3. Vietnam Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.9.2. Taiwan Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.9.3. Taiwan Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 6.4.10.2. Rest of Asia Pacific Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 6.4.10.3. Rest of Asia Pacific Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 7. Middle East and Africa Bipolar Disorder Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 7.2. Middle East and Africa Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 7.3. Middle East and Africa Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 7.4. Middle East and Africa Bipolar Disorder Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 7.4.1.2. South Africa Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 7.4.1.3. South Africa Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 7.4.2.2. GCC Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 7.4.2.3. GCC Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 7.4.3.2. Nigeria Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 7.4.3.3. Nigeria Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 7.4.4.2. Rest of ME&A Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 7.4.4.3. Rest of ME&A Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 8. South America Bipolar Disorder Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 8.2. South America Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 8.3. South America Bipolar Disorder Market Size and Forecast, by Mechanism of Action(2023-2030) 8.4. South America Bipolar Disorder Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 8.4.1.2. Brazil Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 8.4.1.3. Brazil Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 8.4.2.2. Argentina Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 8.4.2.3. Argentina Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Bipolar Disorder Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Rest Of South America Bipolar Disorder Market Size and Forecast, by Treatment type (2023-2030) 8.4.3.3. Rest Of South America Bipolar Disorder Market Size and Forecast, by Mechanism of Action (2023-2030) 9. Global Bipolar Disorder Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Bipolar Disorder Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Johnson & Johnson (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Pfizer Inc. (United States) 10.3. AstraZeneca plc (United Kingdom) 10.4. Eli Lilly and Company (United States) 10.5. Bristol Myers Squibb (United States) 10.6. Otsuka Pharmaceutical Co., Ltd. (Japan) 10.7. Allergan plc (Ireland) 10.8. AbbVie Inc. (United States) 10.9. GlaxoSmithKline plc (United Kingdom) 10.10. Novartis AG (Switzerland) 10.11. Lundbeck (Denmark) 10.12. Alkermes plc (Ireland) 10.13. Sumitomo Dainippon Pharma Co., Ltd. (Japan) 10.14. Takeda Pharmaceutical Company Limited (Japan) 10.15. Mitsubishi Tanabe Pharma Corporation (Japan) 10.16. Sunovion Pharmaceuticals Inc. (United States) 10.17. Boehringer Ingelheim International GmbH (Germany) 10.18. Janssen Pharmaceuticals, Inc. (United States) 10.19. Mylan N.V. (United States) 10.20. Recordati S.p.A. (Italy) 11. Key Findings 12. Industry Recommendations 13. Bipolar Disorder Market: Research Methodology 14. Terms and Glossary